arrow
Y

Yuho Najima

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
H指数:30
被引数:5,219

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peripheral neuropathy after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and electrophysiologic features

异基因造血干细胞移植后的周围神经病变:发生率、危险因素及电生理特征

2026-08-290
PRE
Case Report: Immune-directed post-transplant maintenance with low-dose gemtuzumab ozogamicin and stepwise donor lymphocyte infusion in acute myeloid leukemia with t(1;3)(p36.3;q21)

病例报告:在伴有t(1;3)(p36.3;q21)的急性髓系白血病中,采用低剂量吉姆单抗奥佐米星和逐步供者淋巴细胞输注进行免疫导向的移植后维持治疗

2026-08-070
OA
Absence of Pretransplant Peripheral Blasts is Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia

移植前外周血 blasts 缺失是异基因干细胞移植治疗进展期急性淋巴细胞白血病的有利因素

2026-06-230
PRE
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era

FLT3抑制剂时代FLT3-ITD突变急性髓系白血病异基因造血干细胞移植结局的变化

2026-06-011
PRE
Treatment outcomes of adult B-cell ALL with post-transplant relapse in the era of immunotherapeutic agents

成人B细胞ALL移植后复发的治疗结局在免疫治疗药物时代

2026-05-200
PRE
Vaccine-Induced Anti-HBs Response Is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial

疫苗诱导的抗-HBs反应与异基因造血细胞移植后乙型肝炎病毒再激活的保护作用相关:一项随机试验

2026-05-170
PRE
Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation

异基因造血细胞移植后通过多重血浆PCR检测到的BK多瘤病毒血症的预后影响

2026-03-300
PRE
CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting

CXCR4诱导car-t细胞耗竭后的记忆形成以实现持久的白血病靶向

2026-01-260
OAAI
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation

帕纳替尼/博纳吐莫单抗用于费城染色体阳性复发性白血病作为异基因移植的桥梁治疗

2025-12-311
PRE
Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival After Second Allogeneic Stem Cell Transplantation

新型评分系统:基于老年营养风险指数、C-反应蛋白和疾病状态,预测第二次异基因造血干细胞移植后的生存情况

2025-12-040
PRE
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation

先期实体瘤及其治疗模式对异基因造血干细胞移植后结局的影响

2025-09-150
PRE
Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma

C-反应蛋白/血小板比率作为生物标志物在恶性淋巴瘤异基因造血干细胞移植前的预后价值

2025-09-080
PRE
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study

HCT-VTE-J模型:用于预测同种异基因造血干细胞移植后迟发性静脉血栓栓塞症的日本单中心研究

2025-08-210
PRE
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变及FLT3-ITD急性髓系白血病中可测量的微小残留病的影响

2025-07-030
OAAI
Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis

同种异基因造血干细胞移植后的经典型和迟发型SOS/VOD:一项日本移植登记研究

2025-05-190
PRE
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience
2025-01-290
OAAI